Original Article

The Journal of the Korean Rheumatism Association 2004; 11(4): 387-397

Published online December 30, 2004

© Korean College of Rheumatology

피부섬유아세포에서 저산소증에 의한 Connective Tissue Growth Factor의 발현

홍경희·유승아·강순숙·신용주·김완욱·조철수

가톨릭대학교 의과대학 내과학교실 류마티스내과, 가톨릭의과학연구원

Hypoxia Induces the Expression of Connective Tissue Growth Factor in Dermal Fibroblasts

Kyung-Hee Hong, M.S., Seung-Ah Yoo, M.S., Soon-Sook Kang, M.S., Yong-Ju Shin, M.D., Wan-Uk Kim, M.D, Chul-Soo Cho, M.D.

Division of Rheumatology, Department of Internal Medicine, St. Mary's Hospital, and Catholic Research Institutes of Medical Sciences, The Catholic University of Korea, Seoul, Korea

Correspondence to : Chul-Soo Cho, M.D.

Abstract

Objective: Connective tissue growth factor (CTGF) has been proposed to play a role in fibrotic process of systemic sclerosis. Since hypoxia was known to be associated with fibrosis in several profibrogenic conditions, we investigated whether CTGF expression in dermal fibroblast is regulated by hypoxia caused by microvascular loss. Methods: Dermal fribroblasts from patient with systemic sclerosis and normal controls were cultured in the presence of cobalt chloride (CoCl2), a chemical inducer of HIF-1α or hypoxic culture conditions. Expression of HIF-1α, VEGF and CTGF was evaluated by semiquantitative reverse transcription-polymerase chain reaction and Western blotting. Results: Scleroderma fibroblasts expressed increased levels of HIF-1α, VEGF and CTGF compared to normal dermal fibroblasts. Dermal fibroblasts exposed to various concentration of CoCl2 (1∼100μM) enhanced the expression of CTGF mRNA in dose-dependent fashion. Actinomycin D significantly blocked the hypoxia-mediated up-regulation of CTGF mRNA expression, whereas cycloheximide did not block the up-regulation. Up-regulation of CTGF by hypoxia was not mediated by endogenous production of transforming growth factor (TGF)-β. In time-kinetics study, dermal fibroblasts from scleroderma patients exhibited earlier peak expression of CTGF mRNA than those from normal dermal fibroblasts. In addition, simultaneous treatment of suboptimal concentration of CoCl2 and TGF-β exhibited the up-regulation of CTGF mRNA in additive fashion. Interferon-γ did not modulate the expression of CTGF mRNA induced by CoCl2, while the up-regulation of CTGF by TGF-β was downregulated by Interferon-γ in a dose-dependent fashion. Conclusion: These data indicate that hypoxia up-regulates the expression of CTGF in dermal fibroblasts and provide the evidence that hypoxia caused by microvascular alterations contributes the progression of fibrosis in systemic sclerosis by up-regulation of CTGF.

Keywords Systemic sclerosis, Hypoxia, Connective tissue growth factor, Dermal fibroblast, Transforming gronth factor-β

Article

Original Article

The Journal of the Korean Rheumatism Association 2004; 11(4): 387-397

Published online December 30, 2004

Copyright © Korean College of Rheumatology.

피부섬유아세포에서 저산소증에 의한 Connective Tissue Growth Factor의 발현

홍경희·유승아·강순숙·신용주·김완욱·조철수

가톨릭대학교 의과대학 내과학교실 류마티스내과, 가톨릭의과학연구원

Hypoxia Induces the Expression of Connective Tissue Growth Factor in Dermal Fibroblasts

Kyung-Hee Hong, M.S., Seung-Ah Yoo, M.S., Soon-Sook Kang, M.S., Yong-Ju Shin, M.D., Wan-Uk Kim, M.D, Chul-Soo Cho, M.D.

Division of Rheumatology, Department of Internal Medicine, St. Mary's Hospital, and Catholic Research Institutes of Medical Sciences, The Catholic University of Korea, Seoul, Korea

Correspondence to:Chul-Soo Cho, M.D.

Abstract

Objective: Connective tissue growth factor (CTGF) has been proposed to play a role in fibrotic process of systemic sclerosis. Since hypoxia was known to be associated with fibrosis in several profibrogenic conditions, we investigated whether CTGF expression in dermal fibroblast is regulated by hypoxia caused by microvascular loss. Methods: Dermal fribroblasts from patient with systemic sclerosis and normal controls were cultured in the presence of cobalt chloride (CoCl2), a chemical inducer of HIF-1α or hypoxic culture conditions. Expression of HIF-1α, VEGF and CTGF was evaluated by semiquantitative reverse transcription-polymerase chain reaction and Western blotting. Results: Scleroderma fibroblasts expressed increased levels of HIF-1α, VEGF and CTGF compared to normal dermal fibroblasts. Dermal fibroblasts exposed to various concentration of CoCl2 (1∼100μM) enhanced the expression of CTGF mRNA in dose-dependent fashion. Actinomycin D significantly blocked the hypoxia-mediated up-regulation of CTGF mRNA expression, whereas cycloheximide did not block the up-regulation. Up-regulation of CTGF by hypoxia was not mediated by endogenous production of transforming growth factor (TGF)-β. In time-kinetics study, dermal fibroblasts from scleroderma patients exhibited earlier peak expression of CTGF mRNA than those from normal dermal fibroblasts. In addition, simultaneous treatment of suboptimal concentration of CoCl2 and TGF-β exhibited the up-regulation of CTGF mRNA in additive fashion. Interferon-γ did not modulate the expression of CTGF mRNA induced by CoCl2, while the up-regulation of CTGF by TGF-β was downregulated by Interferon-γ in a dose-dependent fashion. Conclusion: These data indicate that hypoxia up-regulates the expression of CTGF in dermal fibroblasts and provide the evidence that hypoxia caused by microvascular alterations contributes the progression of fibrosis in systemic sclerosis by up-regulation of CTGF.

Keywords: Systemic sclerosis, Hypoxia, Connective tissue growth factor, Dermal fibroblast, Transforming gronth factor-β

JRD
Jan 01, 2025 Vol.32 No.1, pp. 1~7
COVER PICTURE
Cumulative growth of rheumatology members and specialists (1980~2024). Cumulative distribution of the number of the (A) Korean College of Rheumatology members and (B) rheumatology specialists. (J Rheum Dis 2025;32:63-65)

Stats or Metrics

Share this article on

  • line

Related articles in JRD

Journal of Rheumatic Diseases

pISSN 2093-940X
eISSN 2233-4718
qr-code Download